TE_8327
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | SVA_B |
---|---|
TE superfamily | SVA |
TE class | Retroposon |
Gene | -, FHIT |
Class | Chimeric, Intergenic |
Coding | Annoated, Non-coding |
Tumor-specific score | 160.05 |
Counts of samples | TCGA_tumor:141; TCGA_normal:0; GTEx:0 |
TSS | chr3(-):61435007 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_8327.11 | FHIT | Chimeric | Annoated | MSFRFGQHLIKPSVVFLKTELSFALVNRKPVVPGHVLVCPLRPVERFHDLRPDEVADLFQTTQRVGTVVEKHFHGTSLTFSMQDGPEAGQTVKHVHVHVLPRKAGDFHRNDSIYEELQKHDKEDFPASWRSEEEMAAEAAALRVYFQ* | chr3(-):59749548,59749568,59752221,59752321,59922346,59922414,60011371,60011400,60014007,60014152,60536860,60536979,60821919,60822011,61042047,61042099,61200617,61200665,61284618,61284664,61315372,61315482,61317816,61317939,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008 |
teRNA_8327.12 | FHIT | Chimeric | Non-coding | Non-coding | chr3(-):59752301,59752321,59922346,59922414,60011371,60011400,60014007,60014152,60536860,60536979,60821919,60822011,61042047,61042099,61200617,61200665,61284618,61284664,61315372,61315482,61317816,61317939,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008 |
teRNA_8327.13 | FHIT | Chimeric | Non-coding | Non-coding | chr3(-):60014132,60014152,60536860,60536979,60765524,60765563,60821919,60822011,61042047,61042099,61200617,61200665,61284618,61284664,61315372,61315482,61317816,61317939,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008 |
teRNA_8327.14 | FHIT | Chimeric | Non-coding | Non-coding | chr3(-):60536959,60536979,60821919,60822011,61165575,61165828,61166973,61167042,61200617,61200665,61284618,61284664,61315372,61315482,61317816,61317939,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008 |
teRNA_8327.15 | - | Intergenic | Non-coding | Non-coding | chr3(-):61383295,61383315,61405453,61405505,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.